| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/24/2002 | WO2001079851A8 NON-INVASIVE PRENATAL DIAGNOSIS USING CD45-ve FETAL CELLS |
| 01/24/2002 | WO2001079526A3 Live cell procedures to identify compounds modulating intracellular distribution of phosphodiesterase (pde) enzymes |
| 01/24/2002 | WO2001074130A3 A computer based method for identifying conserved invariant peptide motifs |
| 01/24/2002 | WO2001069639A3 Method and apparatus for $m(f)i$m(g)in-vivo$m(f)/i$m(g) measurement of carbon monoxide production rate |
| 01/24/2002 | WO2001064900A3 Aspartate carbamyltransferase as herbicidal target |
| 01/24/2002 | WO2001064750A3 Modulation of the activity of the endothelial cel surface receptor ecrtp/dep-1 in the regulation of angiogenesis |
| 01/24/2002 | WO2001059073A3 Cytotoxic t lymphocytes activated by dendritic cell hybrids |
| 01/24/2002 | WO2001057507B1 Measuring device with a plunge-in electrode |
| 01/24/2002 | WO2001052892A3 Jak/stat pathway inhibitors and the uses thereof |
| 01/24/2002 | WO2001051906A3 Method for quantitative fluid analysis and device for the implementation thereof |
| 01/24/2002 | WO2001051819A3 Oil in air indicator |
| 01/24/2002 | WO2001046258A3 Transporters and ion channels |
| 01/24/2002 | WO2001044286A3 Five-helix protein |
| 01/24/2002 | WO2001042757A3 Sperm quality assay |
| 01/24/2002 | WO2001040801A3 Diagnosis and treatment for helicobacter pylori induced colic |
| 01/24/2002 | WO2001036977A8 Identification of disease markers involving mass-based-separation |
| 01/24/2002 | WO2001036470A3 Methods and compositions for detection and treatment of breast cancer, based on breast cancer-associated polypeptides |
| 01/24/2002 | WO2001036005A3 Targeted delivery of therapeutic and diagnostic moieties |
| 01/24/2002 | WO2001031342A3 DIAGNOSIS AND TREATMENT OF CANCER USING StAR POLYPEPTIDES AND POLYNUCLEOTIDES |
| 01/24/2002 | WO2001025436A3 Endozepine-like polypeptides and polynucleotides encoding same |
| 01/24/2002 | WO2001023409A8 38 human secreted proteins |
| 01/24/2002 | WO2001023387A3 CERTAIN ALKYLENE DIAMINE-SUBSTITUTED PYRAZOLO[1,5,-a]-1,5-PYRIMIDINES AND PYRAZOLO[1,5-a]-1,3,5-TRIAZINES |
| 01/24/2002 | WO2001019860A3 Proteins associated with cell differentiation |
| 01/24/2002 | WO2001016290A3 Dna encoding the human serine protease eos |
| 01/24/2002 | WO2001016181A3 Crystal structures of domains of receptor protein tyrosine kinases and their ligands |
| 01/24/2002 | WO2001012856A3 Analysis of sequence tags with hairpin primers |
| 01/24/2002 | WO2001012819A3 Protein phosphatases and diagnosis and treatment of phosphatase-related disorders |
| 01/24/2002 | WO2000073453A9 T-bet compositions and methods of use thereof |
| 01/24/2002 | WO2000073413A9 Apparatus and method for cell disruption |
| 01/24/2002 | WO2000073338A9 Compositions and methods for the therapy, diagnosis and monitoring of breast cancer |
| 01/24/2002 | WO2000071574A3 Antigenic neisserial peptides |
| 01/24/2002 | WO2000063697A9 Device for the testing of fluid samples and process for making the device |
| 01/24/2002 | US20020010948 Swine defective for transmission of porcine endogenous retrovirus and uses thereof |
| 01/24/2002 | US20020010944 CeSERT genes, proteins, and modulatory compounds |
| 01/24/2002 | US20020010555 Ionization polarity prediction of compounds for efficient mass spectrometry |
| 01/24/2002 | US20020010553 Method for presenting thrombosis and hemostasis assay data |
| 01/24/2002 | US20020010550 Pharmacokinetic-based drug design tool and method |
| 01/24/2002 | US20020010405 Devices, methods and systems for collecting material from a breast duct |
| 01/24/2002 | US20020010324 Genetic engineering; polypeptides |
| 01/24/2002 | US20020010279 Napthalimide boronate derivatives and substituted chlorobenzophenoxazinone boronate derivatives |
| 01/24/2002 | US20020010267 Block copolymers |
| 01/24/2002 | US20020010213 Inhibiting membrane transport mediated by the multidrug resistance associated protein MRP in a patient by administering a compound having an amphiphilic anion and a molecular weight of from 300 to 950 daltons. |
| 01/24/2002 | US20020010212 Assay for D-serine transport antagonist and use for treating psychosis |
| 01/24/2002 | US20020010139 Selective complex of lipoprotein with hemoglobin or hemoglobin analog, and assay method and assaying kit using the complex |
| 01/24/2002 | US20020010137 Methods and compositions for inhibiting neoplastic cell growth |
| 01/24/2002 | US20020010126 Administering an agent which antagonizes the effects of a colony stimulating factor on these monocyte/macrophage cells to lower levels or reduce their activity; treating inflammation |
| 01/24/2002 | US20020010125 Chemokinesis interferes with immune and inflammatory responses by increasing cell movements and altering cell migration patterns; interfere with spread of malignant cells through the body, and reduce inflammatory responses |
| 01/24/2002 | US20020010090 Oxidizing catalysts, carbon monoxide sensor, and hydrogen sensor |
| 01/24/2002 | US20020009812 Apparatus for measuring a medical substance; a sensor for use in the apparatus and a sensing element for use in the sensor |
| 01/24/2002 | US20020009811 Method and apparatus for detection of multiple biological materials with a heterogeneous antibody mixture |
| 01/24/2002 | US20020009810 Electronics methods for the detection of analytes |
| 01/24/2002 | US20020009808 Detecting cancer in humans; obtain sample tissue, detect presence of cadium, amplified amounts indicators cancer |
| 01/24/2002 | US20020009806 Apparatus for propagation of preferential cells and detection of cell propagation modulators |
| 01/24/2002 | US20020009796 Cell activity assay apparatus and methods for making and using same |
| 01/24/2002 | US20020009778 Thyroid and pituitary membrane protein |
| 01/24/2002 | US20020009776 Fibroblast growth factor receptor-like molecules and uses thereof |
| 01/24/2002 | US20020009772 Novel human calcium channels and related probes, cell lines and mehtods |
| 01/24/2002 | US20020009767 Frozen tissue microarrays and methods for using the same |
| 01/24/2002 | US20020009766 Method for quantification of biological material in a sample |
| 01/24/2002 | US20020009764 Antitumor agents for use in treatment of cancer |
| 01/24/2002 | US20020009763 Kit for evaluating glutamic-pyrivic transaminase activity; fo detecting cell damages or cytotoxicity in organs |
| 01/24/2002 | US20020009762 Assay for protein tyrosine phosphatases |
| 01/24/2002 | US20020009761 Superficial zone protein-binding molecules and uses thereof |
| 01/24/2002 | US20020009760 Method of detecting colon cancer |
| 01/24/2002 | US20020009759 Detecting preferential cells in sample; obtain sample, mix with magnetic particles, incubate with label, analyze labeled cells |
| 01/24/2002 | US20020009757 Screening assays for agents that alter inhibitor of apoptosis (IAP) protein regulation of caspase activity |
| 01/24/2002 | US20020009755 Metastatic classification of tumors; obtain tumor biopsy, monitor expression of preferential receptor isoform, amplified quantities of preferential receptor isoform indicates potential for matastasis |
| 01/24/2002 | US20020009754 Quantitative optical analysis of cells; apply cell to support, incubate with marker solution, monitor and evaluate light emission |
| 01/24/2002 | US20020009753 Anticoagulant test |
| 01/24/2002 | US20020009751 Nucleotide sequences coding protein for use in treatment and prevention of metabolic defects |
| 01/24/2002 | US20020009749 Diagnostic drugs for autoimmune diseases |
| 01/24/2002 | US20020009747 Methods and reagents for identifying modulators of neuronal apoptosis |
| 01/24/2002 | US20020009740 Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
| 01/24/2002 | US20020009739 Metastatic breast and colon cancer regulated genes |
| 01/24/2002 | US20020009738 Diagnostic methods based on detecting a breast tumor protein, or mRNA encoding such protein, in a sample; oligonucleotide hybridization and/or amplification to simultaneously detect two or more tissue-specific polynucleotides in a sample |
| 01/24/2002 | US20020009735 Mammary gland chemokine |
| 01/24/2002 | US20020009732 Version with markings to show changes made |
| 01/24/2002 | US20020009726 CD40 associated proteins |
| 01/24/2002 | US20020009724 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| 01/24/2002 | US20020009723 Resonant bio-assay device and test system for detecting molecular binding events |
| 01/24/2002 | US20020009721 Methods and formulations for the separation of biological macromolecul |
| 01/24/2002 | US20020009718 Diagnosing urogenital disorders in humans; obtain tissue sample, detect protein in sample tissue, compare to control |
| 01/24/2002 | US20020009714 Use of azetidinone compounds |
| 01/24/2002 | US20020009713 Detecting modulators of brain cell propagation; incubate neurons with modulator, measure amount of proteins or nucleotide sequences associated with preferential neurons, adjustment in amount of protein present indicates modulator |
| 01/24/2002 | US20020009712 Expression vector for use in the evaluation of gene expression in preferential cells; for monitoring tumor cell migration |
| 01/24/2002 | US20020009711 Detecting preferential cellular activty in sample; provide cells and binding particles, incubate, determine amount of binding within cells by measuring polarized fluorescent light in cell |
| 01/24/2002 | US20020009709 Counting globins in sample; mix globins and binding peptides, incubate detect and count bound globins |
| 01/24/2002 | US20020009708 Reagents and methods for the detection and quantification of vancomycin in biological fluids |
| 01/24/2002 | US20020009461 Porcine neural cells and their use in treatment of neurological deficits due to neurodegenerative diseases |
| 01/24/2002 | US20020009455 Prostate glands; diagnosis, therapy |
| 01/24/2002 | US20020009452 Method for altering undesirable immune responses to polypeptides |
| 01/24/2002 | US20020009451 New monoclonal antibodies which identify the glycoprotein carrying the ca125 epitope |
| 01/24/2002 | US20020009440 Method for separating cells using immunorosettes |
| 01/24/2002 | US20020009416 Modified avidin-type molecules as targeting agents for the liver and cells of the reticuloendothelial system |
| 01/24/2002 | US20020009397 Connecting insertion and storage zones |
| 01/24/2002 | US20020009394 Automated process line |
| 01/24/2002 | US20020009390 System for collecting and locally analyzing a fluid specimen |
| 01/24/2002 | US20020009389 Qualitative analysis |
| 01/24/2002 | US20020009387 Measuring reflection light |
| 01/24/2002 | US20020009119 Environmental heat stress monitor |